125 related articles for article (PubMed ID: 15386328)
1. Serum levels of soluble E-selectin in women with breast cancer.
Sheen-Chen SM; Eng HL; Huang CC; Chen WJ
Br J Surg; 2004 Dec; 91(12):1578-81. PubMed ID: 15386328
[TBL] [Abstract][Full Text] [Related]
2. Serum levels of hepatocyte growth factor in patients with breast cancer.
Sheen-Chen SM; Liu YW; Eng HL; Chou FF
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
[TBL] [Abstract][Full Text] [Related]
3. The relationship between concentrations of circulating soluble E-selectin and clinical, pathological, and biological features in patients with breast cancer.
Hebbar M; Révillion F; Louchez MM; Vilain MO; Fournier C; Bonneterre J; Peyrat JP
Clin Cancer Res; 1998 Feb; 4(2):373-80. PubMed ID: 9516925
[TBL] [Abstract][Full Text] [Related]
4. Increased concentration of soluble E-selectin in the sera of breast cancer patients.
Matsuura N; Narita T; Mitsuoka C; Kimura N; Kannagi R; Imai T; Funahashi H; Takagi H
Anticancer Res; 1997; 17(2B):1367-72. PubMed ID: 9137500
[TBL] [Abstract][Full Text] [Related]
5. Circulating soluble Fas in patients with breast cancer.
Sheen-Chen SM; Chen HS; Eng HL; Chen WJ
World J Surg; 2003 Jan; 27(1):10-3. PubMed ID: 12557031
[TBL] [Abstract][Full Text] [Related]
6. Soluble VCAM-1 and E-selectin in breast cancer: relationship with staging and with the detection of circulating cancer cells.
Silva HC; Garcao F; Coutinho EC; De Oliveira CF; Regateiro FJ
Neoplasma; 2006; 53(6):538-43. PubMed ID: 17167725
[TBL] [Abstract][Full Text] [Related]
7. [Soluble adhesion molecules in female patients with breast carcinoma].
Tesarová P; Kvasnicka J; Umlaufová A; Homolková J; Kalousová M; Tesar V
Cas Lek Cesk; 2003; 142(5):292-9. PubMed ID: 12920795
[TBL] [Abstract][Full Text] [Related]
8. High serum soluble E-selectin levels are associated with postoperative haematogenic recurrence in esophageal squamous cell carcinoma patients.
Shimada Y; Maeda M; Watanabe G; Imamura M
Oncol Rep; 2003; 10(4):991-5. PubMed ID: 12792758
[TBL] [Abstract][Full Text] [Related]
9. Serum levels of soluble intercellular adhesion molecule-1 and E-selectin in metastatic breast carcinoma: correlations with clinicopathological features and prognosis.
Zhang GJ; Adachi I
Int J Oncol; 1999 Jan; 14(1):71-7. PubMed ID: 9863011
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of circulating soluble E-selectin concentrations in node-negative breast cancer patients.
Hebbar M; Révillion F; Louchez MM; Fournier C; Bonneterre J; Peyrat JP
Clin Cancer Res; 1999 Jun; 5(6):1427-33. PubMed ID: 10389928
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of soluble E-selectin in colorectal cancer.
Uner A; Akcali Z; Unsal D
Neoplasma; 2004; 51(4):269-74. PubMed ID: 15254658
[TBL] [Abstract][Full Text] [Related]
13. Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer.
Sheen-Chen SM; Eng HL; Sheen CW; Cheng YF; Chou FF; Chen WJ
Anticancer Res; 1997; 17(4A):2823-6. PubMed ID: 9252723
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma soluble adhesion molecules; ICAM-1, VCAM-1, and E-selectin levels in patients with slow coronary flow.
Turhan H; Saydam GS; Erbay AR; Ayaz S; Yasar AS; Aksoy Y; Basar N; Yetkin E
Int J Cardiol; 2006 Apr; 108(2):224-30. PubMed ID: 16002164
[TBL] [Abstract][Full Text] [Related]
15. Serum protein expression predicts recurrence in patients with early-stage lung cancer after resection.
D'Amico TA; Brooks KR; Joshi MB; Conlon D; Herndon J; Petersen RP; Harpole DH
Ann Thorac Surg; 2006 Jun; 81(6):1982-7; discussion 1987. PubMed ID: 16731117
[TBL] [Abstract][Full Text] [Related]
16. [Effects of chemotherapy on circulating angiogenic factor levels in patients with breast cancer].
Tang JH; Zhao JH; Gong JP; Qin JW; Pan LQ; Xu ZY
Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):210-4. PubMed ID: 17649639
[TBL] [Abstract][Full Text] [Related]
17. The effects of standard anthracycline-based chemotherapy on soluble ICAM-1 and vascular endothelial growth factor levels in breast cancer.
Mills PJ; Parker B; Jones V; Adler KA; Perez CJ; Johnson S; Cohen-Zion M; Marler M; Sadler GR; Dimsdale JE; Ancoli-Israel S
Clin Cancer Res; 2004 Aug; 10(15):4998-5003. PubMed ID: 15297400
[TBL] [Abstract][Full Text] [Related]
18. Elevation of serum soluble E- and P-selectin in patients with hypertension is reversed by benidipine, a long-acting calcium channel blocker.
Sanada H; Midorikawa S; Yatabe J; Yatabe MS; Katoh T; Baba T; Hashimoto S; Watanabe T
Hypertens Res; 2005 Nov; 28(11):871-8. PubMed ID: 16555575
[TBL] [Abstract][Full Text] [Related]
19. Correlation between the serum values of soluble intercellular adhesion molecule-1 and total sialic acid levels in patients with breast cancer.
Basoglu M; Atamanalp SS; Yildirgan MI; Aydinli B; Ozturk G; Akcay F; Oren D
Eur Surg Res; 2007; 39(3):136-40. PubMed ID: 17337890
[TBL] [Abstract][Full Text] [Related]
20. Serum big endothelin-1 levels in female patients with breast cancer.
Yildirim Y; Gunel N; Coskun U; Sancak B; Bukan N; Aslan S; Cetin A
Int Immunopharmacol; 2008 Aug; 8(8):1119-23. PubMed ID: 18550016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
